U.S. Renewable Energy Stock News

NYSE:FNF
NYSE:FNFInsurance

Fidelity National Financial (FNF) Margin Compression And Q4 Loss Test Bullish Growth Narratives

Fidelity National Financial (FNF) has just wrapped up FY 2025 with Q4 revenue of US$4.1b and a basic EPS loss of US$0.43, while trailing 12 month figures show revenue of US$14.5b and basic EPS of US$2.22. Over recent quarters, the company has seen revenue move from US$3.0b in Q1 2025 to over US$4.0b in Q4, with quarterly EPS ranging from US$0.30 to US$1.33 before the latest loss, creating a mixed picture on profitability. For investors, that combination of solid top line, uneven EPS and...
NYSE:CHGG
NYSE:CHGGConsumer Services

Chegg (CHGG) Revenue Slide To US$72.7m Reinforces Bearish Narratives On Growth Prospects

Chegg (CHGG) has just posted its FY 2025 numbers, with fourth quarter revenue of US$72.7 million and a basic EPS loss of US$0.30, while trailing twelve month revenue came in at US$376.9 million with a basic EPS loss of US$0.96. Over recent quarters, revenue has moved from US$143.5 million in Q4 2024 to US$121.4 million in Q1 2025, US$105.1 million in Q2 2025, US$77.7 million in Q3 2025 and US$72.7 million in Q4 2025, alongside quarterly basic EPS losses ranging between US$0.06 and US$0.33...
NYSE:LUCK
NYSE:LUCKHospitality

Lucky Strike Entertainment (LUCK) Returns To Loss In Q2 2026 Challenging Profit Turnaround Narrative

Lucky Strike Entertainment (LUCK) just posted Q2 2026 results with revenue of US$306.9 million and a basic EPS loss of US$0.11, alongside net income excluding extra items of a US$15.1 million loss, keeping the focus squarely on how quickly the business can close the gap to profitability. The company has seen quarterly revenue move from US$300.1 million in Q2 2025 to US$306.9 million in Q2 2026, while basic EPS has shifted from a profit of US$0.17 to a loss of US$0.11 over the same period,...
NYSE:LTC
NYSE:LTCHealth Care REITs

LTC Properties (LTC) Quarterly FFO Recovery Challenges Bearish Narratives On Earnings Quality

LTC Properties (LTC) has just wrapped up FY 2025 with fourth quarter revenue of US$82.5 million, basic EPS of US$2.14, and funds from operations of US$34.9 million, giving investors a clear view of its latest run rate. Over the past year, revenue across the trailing twelve months moved from US$201.6 million to US$257.6 million, while basic EPS over the same window went from US$2.07 to US$2.54. This sets the backdrop for how you might think about the current report and its implications for...
NYSE:MTDR
NYSE:MTDROil and Gas

Matador Resources (MTDR) Margin Compression Challenges Bullish Profitability Narratives After FY 2025 Results

Matador Resources FY 2025 earnings snapshot Matador Resources (MTDR) has just wrapped up FY 2025 with fourth quarter revenue of US$1,008.7 million and basic EPS of US$1.55, alongside net income from ongoing operations of US$192.5 million. Across the year, the company has seen quarterly revenue range from US$852.5 million to US$1,008.7 million, with EPS between US$1.21 and US$1.92, giving investors a clear line of sight on how the top and bottom line have translated into profit over time. With...
NasdaqGM:VITL
NasdaqGM:VITLFood

How Vital Farms’ Profit Swing, Butter Exit and Lawsuits Could Reshape VITL’s Premium Egg Story

Vital Farms has reported past Q1 2026 results showing sales rising to US$187.16 million from US$162.19 million, but swinging from a US$16.9 million profit to a US$1.52 million net loss alongside an employee stock plan shelf registration of about US$26.88 million. At the same time, Vital Farms is winding down its butter line, managing egg oversupply, and facing multiple lawsuits tied to alleged ERP-related disclosure issues, all of which could influence how investors view its core egg-focused...
NasdaqGS:BTSG
NasdaqGS:BTSGHealthcare

Is It Too Late To Consider BrightSpring Health Services (BTSG) After A 129% One Year Surge?

Curious whether BrightSpring Health Services at US$52.74 is offering value or just riding hype? This article walks you through what the current price could mean for you as an investor. The stock has returned 9.5% over the past week, 21.2% over the last 30 days, 37.3% year to date and 128.9% over the past year. This naturally raises questions about how much of the story is already reflected in the price. Recent attention around BrightSpring Health Services has centered on its position in the...
NYSE:FUN
NYSE:FUNHospitality

Is It Time To Reassess Six Flags Entertainment (FUN) After Its Recent Share Price Rebound?

If you are wondering whether Six Flags Entertainment is attractively priced today or a potential value trap in disguise, this article breaks down what the current share price is really offering you. The stock last closed at US$19.69, with returns of 9.3% over the past week, 10.1% over the past month, 27.1% year to date, and a 45.5% decline over the past year as well as 52.2% and 54.1% declines over the last 3 and 5 years. Recent headlines around Six Flags Entertainment have focused on its...
NYSE:SMG
NYSE:SMGChemicals

Scotts Miracle-Gro Lawsuit Puts Governance And Valuation Gap In Focus

A federal judge has allowed key investor fraud claims against Scotts Miracle-Gro (NYSE:SMG) to proceed, focusing on alleged misstatements around demand, inventory, and the Hawthorne cannabis unit. The ruling keeps senior management and the company under legal scrutiny, extending an ongoing securities lawsuit rather than dismissing it outright. This development adds a layer of litigation and governance risk that sits alongside existing discussions of earnings, debt, and recovery efforts. For...
NasdaqCM:RMR
NasdaqCM:RMRReal Estate

Do RMR Group’s (RMR) Mixed Quarterly And Year‑To‑Date Profits Reveal A Deeper Earnings Shift?

The RMR Group Inc. has reported past second-quarter 2026 results, with sales rising to US$5.1 million while revenue fell to US$145.63 million, and quarterly net income declining to US$1.01 million, or US$0.05 per diluted share, compared with the prior year period. Over the first six months of fiscal 2026, higher sales but lower revenue coincided with net income improving to US$13.2 million, highlighting a contrast between weaker quarterly profitability and stronger year‑to‑date earnings. We...
NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

Is It Too Late To Consider Robinhood Markets (HOOD) After Last Year’s 58% Rally?

Wondering if Robinhood Markets at around US$79 per share is still compelling value or if the easy gains are behind it? This article breaks down what the current price really reflects. The stock has been volatile recently, with an 11% return over the last 7 days, 13.3% over the last 30 days, a 31.4% decline year to date, and a 58.1% return over the last year, which can shift how the market is thinking about both opportunity and risk. Recent coverage has focused on Robinhood's evolving role in...
NYSE:MANE
NYSE:MANEPharmaceuticals

Assessing Veradermics (MANE) Valuation After A Sharp 72% One Month Share Price Move

What recent moves in Veradermics (MANE) might be telling you Veradermics (MANE) has drawn attention after a sharp month return of about 72% and a very large past 3 months move, putting its clinical stage dermatology pipeline and valuation in sharper focus for investors. See our latest analysis for Veradermics. The recent 72% 30 day share price return and very large 90 day move sit alongside a 190.78% year to date share price return, which points to strong upward momentum despite a 4.38% one...
NasdaqGS:POOL
NasdaqGS:POOLRetail Distributors

Pool CEO Shakeup And Delayed Investor Day Test Undervalued Thesis

Pool Corporation (NasdaqGS:POOL) has announced the immediate departure of CEO Peter D. Arvan. John B. Watwood has been appointed as the new President and CEO, with John E. Stokely becoming Executive Chair. The company has postponed its upcoming Investor Day following the leadership change. Pool enters this leadership transition after a period of weak share price performance, with NasdaqGS:POOL at $188.09 and showing a 10.3% decline over the past week and 35.2% decline over the past year...
NasdaqGM:OMER
NasdaqGM:OMERPharmaceuticals

Assessing Omeros (OMER) Valuation After Recent Share Price Rebound And Novo Nordisk Deal Prospects

What recent performance signals for Omeros (OMER) Without a single defining headline driving trading, Omeros (OMER) has still drawn attention after a strong month and past 3 months, alongside sizeable 1 year and 3 year total returns. At a recent price of $14.83 and a market cap of about $1.06b, the stock reflects a clinical stage pipeline built around immunologic and rare disease programs rather than current product revenue. See our latest analysis for Omeros. For context, Omeros has paired a...
NYSE:MP
NYSE:MPMetals and Mining

Is It Too Late To Consider MP Materials (MP) After Rare Earth Supply Chain Tailwinds?

To figure out whether MP Materials stock still offers value after its strong run, you need to separate a compelling story about rare earths from what the current share price already reflects. The stock last closed at US$72.65, with returns of 18.5% over 7 days, 42.0% over 30 days, 32.2% year to date, 207.6% over 1 year, 221.7% over 3 years and 192.9% over 5 years, so recent performance is front of mind for many investors. Recent news around rare earth supply chains and US focused production...
NasdaqGS:ASO
NasdaqGS:ASOSpecialty Retail

Is It Too Late To Consider Academy Sports and Outdoors (ASO) After Strong Five Year Return?

Wondering whether Academy Sports and Outdoors at around US$54.46 is still priced attractively, or if most of the easy upside is gone? This article focuses squarely on what the numbers say about value. The stock has returned 4.4% year to date and 36.7% over the past year, while the past 30 days and 7 days show declines of 4.8% and 0.7%. This can change how the market is thinking about risk and opportunity. Recent coverage around Academy Sports and Outdoors has centered on how the business is...
NasdaqCM:PHOE
NasdaqCM:PHOEConstruction

Assessing Phoenix Asia Holdings (NasdaqCM:PHOE) Valuation After Sharp Short Term Share Price Swings

Phoenix Asia Holdings (PHOE) has drawn fresh attention after recent trading, with the stock last closing at $28.60. Investors are weighing its substructure construction focus in Hong Kong against recent short term share price moves. See our latest analysis for Phoenix Asia Holdings. The recent 1 day share price return of 39.14% decline contrasts sharply with the 7 day share price return of 83.92% and the year to date share price return of 76.11%. The 1 year total shareholder return is very...
NYSE:NABL
NYSE:NABLSoftware

Assessing N-able (NABL) Valuation After Narrower Q1 2026 Net Loss Draws Fresh Investor Attention

Q1 earnings highlight a narrower loss N-able (NABL) reported first quarter 2026 earnings with a net loss of US$615,000, compared with a net loss of US$7.16 million a year earlier, drawing fresh attention to the stock. See our latest analysis for N-able. The earnings update comes after a mixed share price stretch, with a 10.17% 1 month share price return, a 27.26% year to date share price decline, and a 25.63% 1 year total shareholder return loss, suggesting momentum has been weak despite...
NYSE:INGM
NYSE:INGMElectronic

Ingram Micro Balances Share Sale With Buyback And Cybersecurity Expansion

Ingram Micro Holding (NYSE:INGM) is seeing a substantial secondary offering by its principal shareholder, an affiliate of Platinum Equity, shifting a meaningful block of ownership. The company has authorized a $30 million share repurchase from the underwriters in connection with this offering, signaling active capital management around the transaction. Separately, Ingram Micro has been selected as a global distribution partner for Huntress, a cybersecurity platform, expanding its reach in...
NYSE:CBT
NYSE:CBTChemicals

Is It Time To Reassess Cabot (CBT) After Its Recent Share Price Strength?

If you are wondering whether Cabot is trading at an attractive price today, or if the recent enthusiasm already reflects its value, this breakdown will help you put the current share price in context. Cabot's stock recently closed at US$82.41, with returns of 8.8% over the past week, 10.8% over the past month, 22.9% year to date and 15.7% over the past year, which can influence how you think about upside and risk. Recent coverage around Cabot has focused on giving investors evergreen context...
NasdaqGS:ALKT
NasdaqGS:ALKTSoftware

Is Alkami Technology (ALKT) Starting To Look Attractive After A 40% One-Year Share Price Fall

If you are wondering whether Alkami Technology at around US$16.75 is starting to look like value or still carries more risk than reward, the recent price history gives you a useful starting point. The stock has moved 2.0% over the last 7 days, is roughly flat over 30 days with a 0.2% decline, but is down 26.1% year to date and 40.2% over the past year, set against a 28.8% gain over 3 years and a 48.7% decline over 5 years. These mixed returns have kept attention on how the business is being...